Detalhe da pesquisa
1.
Non-viral precision T cell receptor replacement for personalized cell therapy.
Nature
; 615(7953): 687-696, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356599
2.
Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot study.
Support Care Cancer
; 30(5): 3829-3838, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034197
3.
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentary.
Future Oncol
; 17(4): 363-369, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397134
4.
Immunotherapy Approaches Beyond PD-1 Inhibition: the Future of Cellular Therapy for Head and Neck Squamous Cell Carcinoma.
Curr Treat Options Oncol
; 20(4): 31, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30874960
5.
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.
Cancer
; 121(3): 432-440, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25250858
6.
Systemic therapy of metastatic melanoma: on the road to cure.
Oncology (Williston Park)
; 29(2): 126-35, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683834
7.
Lifileucel, an Autologous Tumor-infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors.
Cancer Discov
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563600
8.
Impact of HPV status on immune responses in head and neck squamous cell carcinoma.
Oral Oncol
; 127: 105774, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219073
9.
Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function.
Cancer Cell
; 40(4): 393-409.e9, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413271
10.
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade.
Cancer Cell
; 39(2): 193-208.e10, 2021 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33357452
11.
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
Clin Cancer Res
; 26(4): 837-845, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796519
12.
Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations.
Cancer Immunol Res
; 7(6): 910-922, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043415
13.
Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.
J Clin Invest
; 128(4): 1563-1568, 2018 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360643
14.
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 24(22): 5552-5561, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045932
15.
Neutrophils dominate the immune cell composition in non-small cell lung cancer.
Nat Commun
; 8: 14381, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28146145
16.
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.
J Exp Med
; 213(7): 1133-9, 2016 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27242164
17.
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.
J Clin Oncol
; 34(31): 3787-3795, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27269940
18.
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells.
J Immunother Cancer
; 2(1): 36, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25317334
19.
Another LAP in the race.
Cancer Discov
; 2(2): 107-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22585852
20.
A new addition to the PD-1 checkpoint inhibitors for non-small cell lung cancer-the anti-PDL1 antibody-MEDI4736.
Transl Lung Cancer Res
; 3(6): 408-10, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25806336